Prize Winners Gallery
  • 7994746216
  • esicon2017@gmail.com
  • Final list of accepted abstracts for posters and oral papers for communications have been uploaded in the website | Poster preparation guidelines also announced. | Pleased to inform that TCMC has granted 7 credit hours for ESICON2017. This includes 2 for attending pre-conference CME also.
  

Corporate Symposium

Corporate symposiums bring out cutting edge developments in molecules in use and those in research. The speakers in these symposium are key opinion leaders in endocrinology and diabetes. Join our national and international speakers for interesting sessions.

13 October 2017
HALL A

I CaRe for Diabetes (panel discussion with Experts)

Sponsor Boehringer Ingelheim Download Invitation
Speakers Dr. Arpan Dev Bhattacharya
Dr. Unnikrishnan AG
Dr. RV Jayakumar
HALL B

Sponsor AstraZeneca
Part 1
Topic
Lecture  (25 Mins ) / 5 Mins (Q/A)
What we Know and what’s likely to come
– SGLT2i Evolving landscape 
 – Dr AK Singh (Kolkata)
Part 2
Topic
Panel discussion  (30 mins)
Optimizing the use of SGLT2 Inhibitors
– A Clinical Perspective
Moderator Dr Krishna Seshadri (Chennai)
Panel 1 Dr Rajesh Rajput (Rohtak)
Panel 2 Dr Sujoy Ghosh ( Kolkata)
Panel 3 Dr Tiny Nair ( Trivandrum)
Panel 4 Dr Ganapathy Bantwal
HALL C

Sponsor Novartis
Chair Person : Prof. Roy Taylor
Time Topic Speaker
2 Min Welcome and Introduction  
20 Min Connecting the Dots between
T2DM and NAFLD
Dr. Mala Dharmalingam
25 Min Reviewing Insulin resistance in
enhancing management of T2DM
Prof. Roy Taylor
10 Min Panel Discussion Faculty
14 October 2017
HALL A

Sponsor MSD Download Invitation
Time Topic Speaker
6:00-6:20 PM Reducing AIC in the Treatment of
Patients with Type 2 Diabetes:
-Why do we still care?
Dr. J.J. Mukherjee
6:20 PM-6:40 PM Evolving patient care in Type 2
Patients with Type2 Diabetes:
The Role of Cardiovascular safety trials and
What they can tell us about Patient Care.
Dr. A.K. Singh
6:40 PM -7: 00 PM Clarifying the role for DPP-4 inhibitors
in the Treatment of atients with
Type 2 Diabetes at Risk of Heart Failure

Dr. Shashank Joshi
HALL B

Sponsor 8.00 -9.00 AM
IPCA Breakfast Symposium
Chairperson:
Dr. Manoj Chaddha,
DM Endocrinology, Hinduja Hospital, mumbai
8.00 -9.00 AM Topic Speakers
  Inflammation and Diabetes – the Connect Dr. Ms. Mala Dharmalingam,
DM Endocrinology, M S Ramaiah Hospital, Bengaluru
  Role and Relevance of Hydroxychloroquine in the Management of Type 2 Diabetes Mellitus Dr. A G Unnikrishnan,
DM Endocrinology, Chellaram Diabetes Centre, Pune
HALL B

Sponsor Lupin
Topic eGA1c summit
– Getting to the Heart of the Matter
(1) Endocrinologist- Dr. A.H. Zargar, Srinagar
(2) Cardiologist – Dr. Tushar Roy , Delhi
(3) Nephrologist – Dr. D.Chafekar , Nasik
HALL C

Sponsor Novo Nordisk
Time 18:00-19:00PM Topic Speaker
18:00-18:05 Welcome and Introduction ChairPerson
18:05-18:25 Exploring Effects of GLP-1 therapy beyond glycemic benefits
– Cardiovascular & Renal Outcomes
Dr Hans DeVries
( Netherlands )
18:25-18:45 Utilizing innovation for insulin therapy:
Co-formulation of basal & Prandial insulin
Dr Krishna Seshadri
18:45-19:00 Panel Discussion & closure All faculty